Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Document Sciences Corporation was a global provider of customer communications management (CCM) and document automation software. Its flagship product suite, xPression, enabled organizations to automate the creation and delivery of highly personalized, data-driven communications across multiple digital and print channels. While the company served the healthcare and life sciences sectors by streamlining the generation of complex regulatory documentation, insurance policies, and patient communications, it operated as a technology firm rather than a biotechnology or pharmaceutical entity. Founded in 1991 as a spin-off from Xerox, the company was publicly traded on the NASDAQ until its acquisition by EMC Corporation in 2008 for approximately $85 million. Its assets were later integrated into the Documentum business unit and eventually became part of OpenText.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Document Sciences.